MF
NKTR icon

Magnetar Financial’s Nektar Therapeutics NKTR Stock Holding History

Magnetar Financial’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-785
Closed -$273K – 708
2020
Q2 		$273K Buy
+785
New +$245K 0.01% 349
2018
Q3 		– Sell
-611
Closed -$448K – 635
2018
Q2 		$448K Buy
+611
New +$705K 0.01% 295

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Magnetar Financial's NKTR Position: Q3 2020 in Review

Magnetar Financial sold out of Nektar Therapeutics (NKTR) in Q3 2020, closing a stake of 785 shares — an estimated $273K sold.

Magnetar Financial first reported a position in NKTR in Q2 2018 and held it in 2 quarters. The position peaked at $448K in Q2 2018. 248 funds tracked by Wall St. Rank hold NKTR as of Q3 2020.

  • Magnetar Financial reported no remaining Nektar Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Magnetar Financial sold 785 Nektar Therapeutics shares in Q3 2020, an estimated $273K.
  • Magnetar Financial first reported a position in Nektar Therapeutics in Q2 2018 and held it in 2 quarters.
  • Magnetar Financial's Nektar Therapeutics position peaked at $448K in Q2 2018.
  • 248 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2020.

Based on Magnetar Financial's 13F filing for Q3 2020, filed 16 Nov 2020.